Doggrell, Sheila A <br/><br/>
Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?  [electronic resource] 

 -  Expert opinion on pharmacotherapy  10 2018 
 - 1655-1661 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1080/14656566.2018.1519547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 1--drug therapy<br/>Glucagon-Like Peptide-1 Receptor--therapeutic use<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Glucagon-Like Peptide-1 Receptor Agonists